US FDA’s Accelerated Approval Council: Bigger Role, More Transparency Coming?

 
• By Sue Sutter
  
2024/2025 Pink Sheet Perspectives
The expedited withdrawal procedures were pressure-tested by Pepaxto in 2024. (Shutterstock)

More from Pink Sheet Perspectives

More from Pathways & Standards